Exact Mass: 285.2456

Exact Mass Matches: 285.2456

Found 93 metabolites which its exact mass value is equals to given mass value 285.2456, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Pentazocine

(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6-trien-4-ol

C19H27NO (285.2093)


Pentazocine is only found in individuals that have used or taken this drug. It is the first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97)The preponderance of evidence suggests that pentazocine antagonizes the opioid effects by competing for the same receptor sites, especially the opioid mu receptor. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AD - Benzomorphan derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D002491 - Central Nervous System Agents > D000700 - Analgesics

   

1-Methyl-2-nonyl-4(1H)-quinolinone

1-Methyl-2-nonyl-4(1H)-quinolinone; 1-Methyl-2-n-nonyl-4(1H) quinolone; 1-Methyl-2-nonyl-4(1H)-quinolone

C19H27NO (285.2093)


1-Methyl-2-nonyl-4(1H)-quinolinone is a member of quinolines. 1-Methyl-2-nonylquinolin-4(1H)-one is a natural product found in Raulinoa echinata, Tetradium ruticarpum, and other organisms with data available. 1-Methyl-2-nonyl-4(1H)-quinolinone is found in herbs and spices. 1-Methyl-2-nonyl-4(1H)-quinolinone is an alkaloid from Ruta graveolens (rue

   

Myristoylglycine

N-Myristoylglycine, potassium salt

C16H31NO3 (285.2304)


Myristoylglycine is an acylglycine with C-14 fatty acid group as the acyl moiety. Acylglycines 1 possess a common amidoacetic acid moiety and are normally minor metabolites of fatty acids. Elevated levels of certain acylglycines appear in the urine and blood of patients with various fatty acid oxidation disorders. They are normally produced through the action of glycine N-acyltransferase which is an enzyme that catalyzes the chemical reaction: acyl-CoA + glycine ↔ CoA + N-acylglycine. Myristoylglycine is an acylglycine with C-14 fatty acid group as the acyl moiety.

   

(+)-Pentazocine

1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0^{2,7}]trideca-2(7),3,5-trien-4-ol

C19H27NO (285.2093)


   

Dehydroabietylamine

[1,4a-dimethyl-7-(propan-2-yl)-1,2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl]methanamine

C20H31N (285.2456)


   

Pirotiodecane

1-[2-(Decylsulphanyl)ethyl]pyrrolidin-2-one

C16H31NOS (285.2126)


   

14-methyl-2-pentadecenethioamide S-oxide

14-methyl-2-pentadecenethioamide S-oxide

C16H31NOS (285.2126)


   

Dihydroabietylamine

Dihydroabietylamine

C20H31N (285.2456)


   

N-(2-Hydroxyethyl)pentadecanamide

N-(2-Hydroxyethyl)pentadecanamide

C17H35NO2 (285.2668)


   

(-)-histrionicotoxin 285C|(?)-histrionicotoxin 285C|allodihydrohistrionicotoxin

(-)-histrionicotoxin 285C|(?)-histrionicotoxin 285C|allodihydrohistrionicotoxin

C19H27NO (285.2093)


   

2-Decyl-1H-quinolin-4-one

2-Decyl-1H-quinolin-4-one

C19H27NO (285.2093)


   

(2S,3R,E)-2-Amino-4-heptadecene-1,3-diol

(2S,3R,E)-2-Amino-4-heptadecene-1,3-diol

C17H35NO2 (285.2668)


   

3-Methyl-2-nonyl-1H-quinolin-4-one

3-Methyl-2-nonyl-1H-quinolin-4-one

C19H27NO (285.2093)


   

2,4,10-Tetradecatrien-8-ynoic acid piperidide

2,4,10-Tetradecatrien-8-ynoic acid piperidide

C19H27NO (285.2093)


   

(2R,3S)-2-acetamido-3-acetoxydodecane|clavaminol I

(2R,3S)-2-acetamido-3-acetoxydodecane|clavaminol I

C16H31NO3 (285.2304)


   

(2E,9Z)-N-isobutylpentadeca-2,9-diene-12,14-diynamide|2,9-Pentadecadiene-12,14-diynoic acid isobutylamide|pentadeca-2E,9Z-dien-12,14-diynoic acid isobutylamide|pentadeca-2E,9Z-diene-12,14-diynoic acid isobutylamide|pentadeca-2t,9c-dien-12,14-diynoic acid isobutylamide

(2E,9Z)-N-isobutylpentadeca-2,9-diene-12,14-diynamide|2,9-Pentadecadiene-12,14-diynoic acid isobutylamide|pentadeca-2E,9Z-dien-12,14-diynoic acid isobutylamide|pentadeca-2E,9Z-diene-12,14-diynoic acid isobutylamide|pentadeca-2t,9c-dien-12,14-diynoic acid isobutylamide

C19H27NO (285.2093)


   

dehydroabietylamine

(+)-Dehydroabiethylamine

C20H31N (285.2456)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.139 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.136

   

1-methyl-2-nonylquinolin-4-one

NCGC00385599-01!1-methyl-2-nonylquinolin-4-one

C19H27NO (285.2093)


   

Pentazocine

(R)-Pentazocine

C19H27NO (285.2093)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AD - Benzomorphan derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Pentadecanoyl Ethanolamide

N-(2-Hydroxyethyl)pentadecanamide

C17H35NO2 (285.2668)


CONFIDENCE standard compound; INTERNAL_ID 29 INTERNAL_ID 29; CONFIDENCE standard compound

   

1-methyl-2-nonylquinolin-4-one [IIN-based on: CCMSLIB00000845108]

NCGC00385599-01!1-methyl-2-nonylquinolin-4-one [IIN-based on: CCMSLIB00000845108]

C19H27NO (285.2093)


   

1-methyl-2-nonylquinolin-4-one [IIN-based: Match]

NCGC00385599-01!1-methyl-2-nonylquinolin-4-one [IIN-based: Match]

C19H27NO (285.2093)


   

Sphingosine (C17 base)

Sphingosine (C17 base)

C17H35NO2 (285.2668)


   

6-decanamidohexanoic acid

6-decanamidohexanoic acid

C16H31NO3 (285.2304)


   

C17_Sphingosine

C17_Sphingosine

C17H35NO2 (285.2668)


Sphingosine (d17:1) is a 17-carbon sphingosine found in human skin. Sphingosine (d17:1) can be phosphorylated by sphingosine kinases to produce C-17 sphingosine-1-phosphate. Sphingosine C-17 was used as an internal standard for spectral analysis of sphingoid compounds[1][2][3].

   

(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H27NO (285.2093)


   

(2S,6R,7S,8S)-7-((E)-buta-1,3-dien-1-yl)-2-((E)-pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2S,6R,7S,8S)-7-((E)-buta-1,3-dien-1-yl)-2-((E)-pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H27NO (285.2093)


   

(2R,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-(pent-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2R,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-(pent-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H27NO (285.2093)


   

(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-((E)-penta-2,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-((E)-penta-2,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H27NO (285.2093)


   

C17 Sphingosine

2S-amino-4E-heptadecene-1,3R-diol

C17H35NO2 (285.2668)


Sphingosine (d17:1) is a 17-carbon sphingosine found in human skin. Sphingosine (d17:1) can be phosphorylated by sphingosine kinases to produce C-17 sphingosine-1-phosphate. Sphingosine C-17 was used as an internal standard for spectral analysis of sphingoid compounds[1][2][3].

   

18-AMINOABIETA-8,11,13-TRIENE

18-AMINOABIETA-8,11,13-TRIENE

C20H31N (285.2456)


   

Leelamine (hydrochloride)

1R,2,3,4,4aS,9,10,10aR-octahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenemethanamine, monohydrochloride

C20H31N (285.2456)


   

Pentadecanoyl-EA

N-(Pentadecanoyl)-ethanolamine

C17H35NO2 (285.2668)


   

15-methyl-hexadecasphingosine

iso (4E,15-methyl-d16:1) sphingosine

C17H35NO2 (285.2668)


   

14-methyl-hexadecasphingosine

anteiso (4E,14-methyl-d16:1) sphingosine

C17H35NO2 (285.2668)


   

1-methyl-2-nonyl-4(1h)-quinolinone

1-methyl-2-nonyl-1,4-dihydroquinolin-4-one

C19H27NO (285.2093)


   

NAE 15:0

N-(Pentadecanoyl)-ethanolamine

C17H35NO2 (285.2668)


   

SPB 17:1;O2

anteiso (4E,14-methyl-d16:1) sphingosine

C17H35NO2 (285.2668)


   

((1S,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDROPHENANTHREN-1-YL)METHANAMINE

((1S,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDROPHENANTHREN-1-YL)METHANAMINE

C20H31N (285.2456)


   

b-Alanine, N-tetradecyl-

b-Alanine, N-tetradecyl-

C17H35NO2 (285.2668)


   

1-BOC-2-[(2-DIMETHYLAMINO-ETHYLAMINO)-METHYL]-PIPERIDINE

1-BOC-2-[(2-DIMETHYLAMINO-ETHYLAMINO)-METHYL]-PIPERIDINE

C15H31N3O2 (285.2416)


   

1-BOC-3-(2-MORPHOLIN-4-YL-ETHYLAMINO)-AZETIDINE

1-BOC-3-(2-MORPHOLIN-4-YL-ETHYLAMINO)-AZETIDINE

C14H27N3O3 (285.2052)


   

1-Decyl-3-methylimidazolium nitrate

1-Decyl-3-methylimidazolium nitrate

C14H27N3O3 (285.2052)


   

tert-butyl N-[(1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl]carbamate

tert-butyl N-[(1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl]carbamate

C14H27N3O3 (285.2052)


   

(S)-TERT-BUTYL 3-(TERT-BUTYLCARBAMOYL)PIPERAZINE-1-CARBOXYLATE

(S)-TERT-BUTYL 3-(TERT-BUTYLCARBAMOYL)PIPERAZINE-1-CARBOXYLATE

C14H27N3O3 (285.2052)


   

(R)-4-BOC-PIPERAZINE-2-CARBOXYL-T-BUTYLAMIDE

(R)-4-BOC-PIPERAZINE-2-CARBOXYL-T-BUTYLAMIDE

C14H27N3O3 (285.2052)


   

Pirotiodecane

Pirotiodecane

C16H31NOS (285.2126)


   

Dodecyl 2-(dimethylamino)propanoate

Dodecyl 2-(dimethylamino)propanoate

C17H35NO2 (285.2668)


   

6-(Decanoylamino)hexanoic acid

6-(Decanoylamino)hexanoic acid

C16H31NO3 (285.2304)


   

5-Amino-6-cyclohexyl-4-hydroxy-2-isobutyl-hexanoic acid

5-Amino-6-cyclohexyl-4-hydroxy-2-isobutyl-hexanoic acid

C16H31NO3 (285.2304)


   

omega-Hydroxy-15-methylpalmitate

omega-Hydroxy-15-methylpalmitate

C17H33O3- (285.243)


A hydroxy fatty acid anion that is the conjugate base of omega-hydroxy-15-methyl-palmitic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

Leelamine

Leelamine

C20H31N (285.2456)


   

4-Heptadecene-1,3-diol, 2-amino-, (2S,3R,4E)-

4-Heptadecene-1,3-diol, 2-amino-, (2S,3R,4E)-

C17H35NO2 (285.2668)


   

3-Dehydro-15-methylhexadecasphinganine

3-Dehydro-15-methylhexadecasphinganine

C17H35NO2 (285.2668)


   

11-Oxomiltiradiene(1-)

11-Oxomiltiradiene(1-)

C20H29O- (285.2218)


An organic anion that is the conjugate base of 11-oxomiltiradiene, arising from the deprotonation of the methylene group at position 14. Major species at pH 7.3.

   

(Z)-cyclopropyl-methoxymycolate

(Z)-cyclopropyl-methoxymycolate

C16H29O4- (285.2066)


   

N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]acetamide

N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]acetamide

C16H31NO3 (285.2304)


   

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]octanamide

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]octanamide

C16H31NO3 (285.2304)


   

N-[(E)-1,3-dihydroxynon-4-en-2-yl]heptanamide

N-[(E)-1,3-dihydroxynon-4-en-2-yl]heptanamide

C16H31NO3 (285.2304)


   

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]pentanamide

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]pentanamide

C16H31NO3 (285.2304)


   

N-[(E)-1,3-dihydroxydec-4-en-2-yl]hexanamide

N-[(E)-1,3-dihydroxydec-4-en-2-yl]hexanamide

C16H31NO3 (285.2304)


   

N-[(E)-1,3-dihydroxytridec-4-en-2-yl]propanamide

N-[(E)-1,3-dihydroxytridec-4-en-2-yl]propanamide

C16H31NO3 (285.2304)


   

N-[(E)-1,3-dihydroxydodec-4-en-2-yl]butanamide

N-[(E)-1,3-dihydroxydodec-4-en-2-yl]butanamide

C16H31NO3 (285.2304)


   

1-Octyl-2,2,6,6-tetramethyl-2,6-disilapiperidine

1-Octyl-2,2,6,6-tetramethyl-2,6-disilapiperidine

C15H35NSi2 (285.2308)


   

Talwin

Talwin

C19H27NO (285.2093)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D002491 - Central Nervous System Agents > D000700 - Analgesics

   

N-Myristoylglycine

N-Myristoylglycine

C16H31NO3 (285.2304)


An N-acylglycine in which the acyl group is specified as myristoyl (tetradecanoyl).

   

Sphingosine (d17:1)

SPH(d17:1)

C17H35NO2 (285.2668)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   

Cer 14:1;O2/2:0

Cer 14:1;O2/2:0

C16H31NO3 (285.2304)


   
   

Cer 8:1;O2/8:0

Cer 8:1;O2/8:0

C16H31NO3 (285.2304)


   

n-[(2r,3s)-3-(acetyloxy)dodecan-2-yl]ethanimidic acid

n-[(2r,3s)-3-(acetyloxy)dodecan-2-yl]ethanimidic acid

C16H31NO3 (285.2304)


   

(2e,4e,10z)-1-(piperidin-1-yl)tetradeca-2,4,10-trien-8-yn-1-one

(2e,4e,10z)-1-(piperidin-1-yl)tetradeca-2,4,10-trien-8-yn-1-one

C19H27NO (285.2093)


   

n-(2-methylpropyl)pentadeca-2,9-dien-12,14-diynimidic acid

n-(2-methylpropyl)pentadeca-2,9-dien-12,14-diynimidic acid

C19H27NO (285.2093)


   

(2e,9z)-n-(2-methylpropyl)pentadeca-2,9-dien-12,14-diynimidic acid

(2e,9z)-n-(2-methylpropyl)pentadeca-2,9-dien-12,14-diynimidic acid

C19H27NO (285.2093)


   

(2s,6r,7s,8r)-7-[(1e)-buta-1,3-dien-1-yl]-2-[(2z)-pent-2-en-4-yn-1-yl]-1-azaspiro[5.5]undecan-8-ol

(2s,6r,7s,8r)-7-[(1e)-buta-1,3-dien-1-yl]-2-[(2z)-pent-2-en-4-yn-1-yl]-1-azaspiro[5.5]undecan-8-ol

C19H27NO (285.2093)


   

(2s,3s)-n-[(1s)-1-(c-hydroxycarbonimidoyl)-3-methylbutyl]-2-[(1-hydroxyethylidene)amino]-3-methylpentanimidic acid

(2s,3s)-n-[(1s)-1-(c-hydroxycarbonimidoyl)-3-methylbutyl]-2-[(1-hydroxyethylidene)amino]-3-methylpentanimidic acid

C14H27N3O3 (285.2052)


   

(2s,6r,7s,8s)-7-[(1z)-but-1-en-3-yn-1-yl]-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2s,6r,7s,8s)-7-[(1z)-but-1-en-3-yn-1-yl]-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H27NO (285.2093)


   

n-[1-(c-hydroxycarbonimidoyl)-3-methylbutyl]-2-[(1-hydroxyethylidene)amino]-3-methylpentanimidic acid

n-[1-(c-hydroxycarbonimidoyl)-3-methylbutyl]-2-[(1-hydroxyethylidene)amino]-3-methylpentanimidic acid

C14H27N3O3 (285.2052)


   

n-methyl-n-(2-methylpropyl)tetradeca-2,4-dien-8,10-diynamide

n-methyl-n-(2-methylpropyl)tetradeca-2,4-dien-8,10-diynamide

C19H27NO (285.2093)


   

7-(but-1-en-3-yn-1-yl)-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

7-(but-1-en-3-yn-1-yl)-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H27NO (285.2093)


   

1-(piperidin-1-yl)tetradeca-2,4,10-trien-8-yn-1-one

1-(piperidin-1-yl)tetradeca-2,4,10-trien-8-yn-1-one

C19H27NO (285.2093)


   

(2e,4e)-n-methyl-n-(2-methylpropyl)tetradeca-2,4-dien-8,10-diynamide

(2e,4e)-n-methyl-n-(2-methylpropyl)tetradeca-2,4-dien-8,10-diynamide

C19H27NO (285.2093)


   

n-[3-(acetyloxy)dodecan-2-yl]ethanimidic acid

n-[3-(acetyloxy)dodecan-2-yl]ethanimidic acid

C16H31NO3 (285.2304)


   

(2s,6r,7s,8r)-7-(buta-1,3-dien-1-yl)-2-(pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2s,6r,7s,8r)-7-(buta-1,3-dien-1-yl)-2-(pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H27NO (285.2093)


   

(2e,4e)-n-(3-methylbutyl)tetradeca-2,4-dien-8,10-diynimidic acid

(2e,4e)-n-(3-methylbutyl)tetradeca-2,4-dien-8,10-diynimidic acid

C19H27NO (285.2093)


   

(2e)-14-methyl-1-sulfinylidenepentadec-2-en-1-amine

(2e)-14-methyl-1-sulfinylidenepentadec-2-en-1-amine

C16H31NOS (285.2126)